Phase III Study of Vincristine Sulfate Liposome Or Vincristine Sulfate For Injection Combined Chemotherapy as Initial Induction Regimen In Adults Acute Lymphoblastic Leukemia
Phase III Study of Vincristine Sulfate Liposome Or Vincristine Sulfate For Injection Combined Chemotherapy as Initial Induction Regimen In Adults Acute Lymphoblastic Leukemia
The purpose of this study is to determine whether vincristine sulfate liposome could reduce less peripheral neuropathy than vincristine sulfate,and be as effective as vincristine sulfate in adults with Naïve Acute Lymphoblastic Leukemia.
Inclusion Criteria:
De novo untreated ALL patients diagnosed by the bone marrow morphology, immunophenotype.
65 ≥ Age (years) ≥ 18 , male or female,
ECOG Performance status of 0, 1, or 2.
Patients must fulfill the following laboratory values
Didn't receive any of the following treatments within 4 weeks before inclusion: chemotherapy, radiotherapy, replacement therapy, operation, long term of glucocorticoid therapy(>5 days).
No neurological disorders, no nerve or muscle injury (motor and sensory nerve).
Patient must sign the informed consent and obey the protocol.
Exclusion Criteria:
86-10-22-23909999